AQP4 invalidation disrupts the chronic fluoxetine-induced enhancement of adult mouse hippocampal neurogenesis (which is also a process crucially involved in the AD response; see next section) as well as AD-evoked behavioral improvement under both basal conditions and a chronic, mild stress-evoked depressive state (Kong et al., 2009). This evidence concerns the gene AQP4 and Alzheimer disease.